贵州省苗药发展及标准现状研究  

Present Status and Development of Guizhou miao medicine

作　　者：刘兴鹏[1] 茅向军[1] 熊慧林[1] 周兰[1] 

机构地区：[1]贵州省食品药品检验所,贵阳550004

出　　处：《中国药事》2015年第12期1250-1255,共6页Chinese Pharmaceutical Affairs

基　　金：国家食品药品监督管理总局药化注册司专项"九省区民族药质量标准现状调研与分析"

摘　　要：目的:为促进我国民族药产业发展提供参考。方法:调研统计苗药品种108个、苗药药材419个,,分析其质量标准涵盖、组成、分布情况,阐述苗药现状及产业政策,分析制约苗药发展的因素,并针对问题提出相关建议。结果与结论:应健全和完善民族药制度,整理、挖掘、研究苗医体系理论基础,强化财政扶持和人才支撑,积极开展苗药发展的纵向合作,建立完善苗药资源可持续开发和利用机制,推进苗药知识产权保护。Objective： To provide reference for promoting the development of traditional Chinese medicines＇ industry. Methods： Totally 419 kinds Miao minority＇s traditional medicines affiliate to 108 species were selected, and their situation of content, composition, distribution, etc, were analyzed. The present situation and industrial policies of Miao medicines was stated. Combining with the research, serious factors which are restricting the development of Miao medicines were analyzed and related suggestions for solving the problems were provided.Results and Conclusion： It is necessary to improve and perfect the system of traditional Chinese medicines, document, deep and study the theoretical basis of Miao minority＇s medical system, intensify support both in finance and talents, develop vertical cooperation of Miao minority＇s medicines, establish and perfect the consistent development and utilization of the resource of traditional Miao minority＇s medicines, so as to accelerate the protection for intellectual property of Miao minority＇s traditional medicines

关 键 词：贵州省 苗药 质量标准 研究报告 

分 类 号：R284[医药卫生—中药学]